Association of CTLA-4 and IL-13 gene polymorphisms with Graves' disease and ophthalmopathy in Chinese children

Investigative Ophthalmology and Visual Science

Volumn 49, Issue 6, 2008, Pages 2409-2415

  Chong, Kelvin K L ^a   Chiang, Sylvia W Y ^a   Wong, Gary W K ^a   Tam, Pancy O S ^a   Ng, Tsz Kin ^a   Hu, Yi Jun ^a,b   Yam, Gary H F ^a   Lam, Dennis S C ^a   Pang, Chi Pui ^a  

^a CHINESE UNIVERSITY OF HONG KONG   (Hong Kong)

^b SHANTOU UNIVERSITY MEDICAL COLLEGE   (China)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOTOXIC T LYMPHOCYTE ANTIGEN 4; IMMUNOGLOBULIN E; INTERLEUKIN 13; CYTOTOXIC T-LYMPHOCYTE ANTIGEN 4; LEUKOCYTE ANTIGEN;

3' UNTRANSLATED REGION; ADOLESCENT; ALLELE; ARTICLE; CHILD; CONTROL GROUP; CONTROLLED STUDY; DNA POLYMORPHISM; EXOPHTHALMOS; EYE DISEASE; FEMALE; GENETIC RISK; GENOTYPE; GRAVES DISEASE; HAPLOTYPE; HUMAN; MAJOR CLINICAL STUDY; MALE; PRESCHOOL CHILD; PREVALENCE; PRIORITY JOURNAL; SCHOOL CHILD; SINGLE NUCLEOTIDE POLYMORPHISM; ASIAN; CASE CONTROL STUDY; CHINA; DINUCLEOTIDE REPEAT; ENDOCRINE OPHTHALMOPATHY; ETHNOLOGY; GENE FREQUENCY; GENETICS;

3' UNTRANSLATED REGIONS; ADOLESCENT; ANTIGENS, CD; ASIAN CONTINENTAL ANCESTRY GROUP; CASE-CONTROL STUDIES; CHILD; CHILD, PRESCHOOL; CHINA; DINUCLEOTIDE REPEATS; FEMALE; GENE FREQUENCY; GENOTYPE; GRAVES DISEASE; GRAVES OPHTHALMOPATHY; HUMANS; INTERLEUKIN-13; MALE; POLYMORPHISM, SINGLE NUCLEOTIDE;

EID: 47249112963     PISSN: 01460404     EISSN: 15525783     Source Type: Journal    
DOI: 10.1167/iovs.07-1433     Document Type: Article

References (64)

1. Bellur S. Prabhakar, Bahn RS, Smith TJ. Current perspective on the pathogenesis of Graves' disease and ophthalmopathy. Endocr Rev. 2003;24:802-835. (Pubitemid 38067700)
2. Lavard L, Ranlov I, Perrild H, Anderson O, Jacobsen BB. Incidence of juvenile thyrotoxicosis in Denmark 1982-1988: a nationwide study. Eur J Endocrinol. 1994;130:565-568.
3. Wong GW, Cheng PS. Increasing incidence of childhood Graves' disease in Hong Kong: a follow-up study. Clin Endocrinol. 2001;54:547-550. (Pubitemid 34204192)
4. Bahn RS, Heufelder AE. Pathogenesis of Graves' ophthalmopathy. N Engl J Med. 1993;329:1468-1475. (Pubitemid 23335894)
5. Carter JA, Utiger RD. The ophthalmopathy of Graves' disease. Ann Rev Med. 1992;43:487-495.
6. Yeatts RP. Quality of life in patients with Graves ophthalmopathy. Trans Am Ophthalmol Soc. 2005;103:368-411. (Pubitemid 43042098)
7. Krassas GE, Segni M, Wiersinga WM. Childhood Graves' ophthalmopathy: results of a European questionnaire study. Eur J Endocrinol. 2005;153:515-521. (Pubitemid 41556278)
8. Krassas GE. Treatment of juvenile Graves' disease and its ophthalmic complication: the 'European way'. Eur J Endocrinol. 2004;150:407-414.
9. Chan W, Wong GW, Fan DS, Cheng AC, Lam DS, Ng JS. Ophthalmopathy in childhood Graves' disease. Br J Ophthalmol. 2002;86:740-742. (Pubitemid 34713158)
10. Gruters A. Ocular manifestations in children and adolescents with thyrotoxicosis. Exp Clin Endocrinol Diabetes. 1999;107(suppl 5):S172-S174.
11. Uretsky SH, Kennerdell JS, Gutai JP. Graves' ophthalmopathy in childhood and adolescence. Arch of Ophthalmol. 1980;98:1963-1964. (Pubitemid 11250644)
12. Young LA. Dysthyroid ophthalmopathy in children. J Pediatr Ophthalmol Strabismus. 1979;16:105-107.
13. Krassas GE, Gogakos A. Thyroid-associated ophthalmopathy in juvenile Graves' disease: clinical, endocrine and therapeutic aspects. J Pediatr Endocrinol Metab. 2006;19:1193-1206. (Pubitemid 44823449)
14. Prummel MF, Bakker A, Wiersinga WM, et al. Multicenter study on the characteristics and treatment strategies of patients with Graves orbitopathy: the first European Group on Graves' Orbitopathy experience. Eur J Endocrinol. 2003;148:491-495. (Pubitemid 36622154)
15. Bartalena L, Marcocci C, Pinchera A. Graves' ophthalmopathy: a preventable disease? Eur J Endocrinol. 2002;146:457-461. (Pubitemid 34436455)
16. Bednarczuk T, Gopinath B, Ploski R, Wall JR. Susceptibility genes in Graves' ophthalmopathy: searching for a needle in a haystack? Clin Endocrinol. 2007;67:3-19. (Pubitemid 46955456)
17. Villanueva R, Tomer Y, Greenberg DA, et al. Autoimmune thyroid disease susceptibility loci in a large Chinese family. Clin Endocrinol. 2002;56:45-51. (Pubitemid 34107321)
18. Vaidya B, Imrie H, Perros P, et al. The cytotoxic T lymphocyte antigen-4 is a major Graves' disease locus. Hum Mol Gen. 1999;8:1195-1199. (Pubitemid 29328987)
19. Brix TH, Kyvik KO, Christensen K, Hegedus L. Evidence for a major role of heredity in Graves' disease: a population-based study of two Danish twin cohorts. J Clin Endocrinol Metab. 2001;86:930-934. (Pubitemid 32207518)
20. Tomer Y, Greenberg DA, Concepcion E, Ban Y, Davies TF. Thyroglobulin is a thyroid specific gene for the familial autoimmune thyroid diseases. J Clin Endocrinol Metab. 2002;87:404-407. (Pubitemid 34084722)
21. Ohtsuka K, Nakamura Y. Human leukocyte antigens associated with hyperthyroid Graves ophthalmology in Japanese patients. Am J Ophthalmol. 1998;126:805-810. (Pubitemid 29001630)
22. Buzzetti R, Nistico L, Signore A, Cascino I. CTLA-4 and HLA gene susceptibility to thyroid-associated orbitopathy. Lancet. 1999;354:1824.
23. Siegmund T, Usadel KH, Donner H, Braun J, Walfish PG, Badenhoop K. Interferon-gamma gene microsatellite polymorphisms in patients with Graves' disease. Thyroid 1998;8:1013-1017. (Pubitemid 28551080)
24. Kamizono S, Hiromatsu Y, Seki N, et al. A polymorphism of the 50 flanking region of tumor necrosis factor a gene is associated with thyroid-associated ophthalmopathy in Japanese. Clin Endocrinol. 2000;52:759-764. (Pubitemid 30409269)
25. Muhlberg T, Kirchberger M, Spitzweg C, Herrman F, Heberling HJ, Heufelder AE. Lack of association of Graves' disease with A2 allele of the interleukin-1 receptor antagonist gene in a white European population. Eur J Endocrinol. 1998;138:686-690. (Pubitemid 28313820)
26. Hunt PJ, Marshall SE, Weetman AP, Bell JI, Wass JAH, Welsh KI. Cytokine gene polymorphisms in autoimmune thyroid disease. J Clin Endocrinol Metab. 2000;85:1984-1988. (Pubitemid 32269309)
27. Gough SC, Walker LS, Sansom DM. CTLA. 4 gene polymorphism and autoimmunity. Immunol Rev. 2005;24:102-115. (Pubitemid 40460496)
28. Hadj Kacem H, Bellassoued M, Bougacha-Elleuch N, Abid M, Ayadi H. CTLA-4 gene polymorphisms in Tunisian patients with Graves' disease. Clin Immunol. 2001;101:361-365. (Pubitemid 33145020)
29. Petrone A, Giorgi G, Galgani A, et al. CT60 single nucleotide polymorphisms of the cytotoxic T-lymphocyte-associated antigen-4 gene region is associated with Graves' disease in an Italian population. Thyroid. 2005;15:232-238. (Pubitemid 40418690)
30. Yung E, Cheng PS, Fok TF, Wong GW. CTLA-4 gene A-G polymorphism and childhood Graves' disease. Clin Endocrinol. 2002;56:649. (Pubitemid 34595734)
31. Bednarczuk T, Hiromatsu Y, Fukutani T, et al. Association of cytotoxic T-lymphocyte-associated antigen-4 (CTLA-4) gene polymorphism and non-genetic factors with Graves' ophthalmopathy in European and Japanese populations. Eur J Endocrinol. 2003;148:13-18. (Pubitemid 36175999)
32. Ueda H, Howson JM, Esposito L, et al. Association of the T-cell regulatory gene CTLA4 with susceptibility to autoimmune disease. Nature. 2003;423:506. (Pubitemid 36648570)
33. Furugaki K, Shirasawa S, Ishikawa N, et al. Association of the T-cell regulatory gene CTLA4 with Graves' disease and autoimmune thyroid disease in the Japanese. J Hum Genet. 2004;49:166-168. (Pubitemid 38506731)
34. Villanueva R, Inzerillo AM, Tomer Y, et al. Limited genetic susceptibility to severe Graves' ophthalmopathy: no role for CTLA-4 but evidence for an environmental etiology. Thyroid. 2000;10:791-798.
35. Han S, Zhang S, Zhang W, et al. CTLA4 polymorphisms and ophthalmopathy in Graves' disease patients: association study and meta-analysis. Hum Immunol. 2006;67:618-626. (Pubitemid 44205330)
36. Chomarat P, Banchereau J. Interleukin-4 and interleukin-13: their similarities and discrepancies. Int Rev Immunol. 1998;17:1-52. (Pubitemid 29014544)
37. Punnonen J, Aversa G, Cocks BG, et al. Interleukin 13 induces interleukin 4-independent IgG4 and IgE synthesis and CD23 expression by human B cells. Proc Natl Acad Sci USA. 1993;90:3730-3734. (Pubitemid 23111441)
38. Raikow RB, Dalbow MH, Kennerdell JS, et al. Immunohistochemical evidence for IgE involvement in Graves' orbitopathy. Ophthalmology. 1990;97:629-635. (Pubitemid 20150718)
39. Sato A, Takemura Y, Yamada T, et al. A possible role of immunoglobulin E in patients with hyperthyroid Graves' disease. J Clin. Endocrinol Metab. 1999;84:3602-3605. (Pubitemid 30645212)
40. Komiya I, Yamada T, Sato A, et al. Remission and recurrence of hyperthyroid Graves' disease during and after methimazole treatment when assessed by IgE and interleukin 13. J Clin Endocrinol Metab. 2001;86:3540-3544. (Pubitemid 32755941)
41. van der Pouw Kraan TC, van Veen A, Boeije LC, et al. An IL-13 promoter polymorphism associated with increased risk of allergic asthma. Genes Immun. 1999;1:61-65. (Pubitemid 129622782)
42. Graves PE, Kabesch M, Halonen M, et al. A cluster of seven tightly linked polymorphisms in the IL-13 gene is associated with total serum IgE levels in three populations of white children. J Allergy Clin Immunol. 2000;105:506-513. (Pubitemid 30169909)
43. Werner SC. Modification of the classification of the eye changes of Graves' disease: recommendations of the Ad Hoc Committee of the American Thyroid Association. J Clin Endocrinol Metab. 1977;44:203-204. (Pubitemid 8030805)
44. Quant JR, Woo GC. Normal values of eye position and head size in Chinese children from Hong Kong. Optom Vis Sci. 1993;70:668-671. (Pubitemid 23231234)
45. Sallakci N, Bacanli A, Coskun M, Yavuzer U, Alpsoy E, Yegin O. CTLA-4 gene 49A/G polymorphism in Turkish patients with Behçet's disease. Clin and Exp Derm. 2005;30:546-550. (Pubitemid 41076025)
46. Shine B, Fells P, Edwards OM, Weetman AP. Association between Graves' ophthalmopathy and smoking. Lancet. 1990;335:1261-1263. (Pubitemid 20181791)
47. Kendler DL, Lippa J, Rootman J. The initial clinical characteristics of Graves' orbitopathy vary with age and sex. Arch Ophthalmol. 1993;111:197-201. (Pubitemid 23053567)
48. Bartalena L, Marcocci C, Bogazzi F, et al. Relation between therapy for hyperthyroidism and the course of Graves' ophthalmopathy. N Engl J Med. 1998;338:73-78. (Pubitemid 28042269)
49. Bartalena L, Marcocci C, Tanda ML, et al. Cigarette smoking and treatment outcomes in Graves ophthalmopathy. Ann Intern Med. 1998;129:632-635. (Pubitemid 28480819)
50. Iwama S, Ikezaki A, Kikuoka N, et al. Association of HLA-DR, -DQ genotype and CTLA-4 gene polymorphism with Graves' disease in Japanese children. Horm Res. 2005;63:55-60. (Pubitemid 40591465)
51. Vaidya B, Imrie H, Perros P, et al. Cytotoxic T lymphocyte antigen-4 (CTLA4) gene polymorphism confers susceptibility to thyroid-associated orbitopathy. Lancet. 1999;354:743-744. (Pubitemid 29405794)
52. Vaidya B, Oakes EJ, Imrie H, et al. CTLA4 gene and Graves' disease: association of Graves' disease with the CTLA4 exon 1 and intron 1 polymorphisms, but not with the promoter polymorphism. Clin Endocrinol. 2003;58:732-735. (Pubitemid 36702733)
53. Han SZ, Zhang SH, Li R, Zhang WY, Li Y. The common -318C/T polymorphism in the promoter region of CTLA4 gene is associated with reduced risk of ophthalmopathy in Chinese Graves' patients. Int J Immunogenet. 2006;33:281-287. (Pubitemid 44086970)
54. http://www.hapmap.org/cgi-perl/snp-details?name=rs5742909&source= hapmap-B36.
55. Hiromatsu Y, Fukutani T, Ichimura M, et al. Interleukin-13 gene polymorphisms confer the susceptibility of Japanese populations to Graves' disease. J Clin Endocrinol Metab. 2005;90:296-301. (Pubitemid 40116671)
56. Molnar I, Horvath S, Balazs C. Detectable serum IgE levels in Graves' ophthalmopathy. Eur J Med Res. 1996;1:543-546.
57. Ajjan RA, Watson PF, Weetman AP. Detection of IL-12, IL-13, and IL-15 messenger ribonucleic acid in the thyroid of patients with autoimmune thyroid disease. J Clin Endocrinol Metab. 1997;82:666-669. (Pubitemid 27068648)
58. Wakelkamp IM, Bakker O, Baldeschi L, Wiersinga WM, Prummel MF. TSH-R expression and cytokine profile in orbital tissue of active vs. inactive Graves' ophthalmopathy patients. Clin Endocrinol. 2003;58:280-287. (Pubitemid 36308115)
59. Heinzmann A, Mao XQ, Akaiwa M, et al. Genetic variants of IL-13 signalling and human asthma and atopy. Hum Mol Gen. 2000;9:549-559. (Pubitemid 30154013)
60. Berezin C, Glaser F, Rosenberg J, et al. ConSeq: the identification of functionally and structurally important residues in protein sequences. Bioinformatics. 2004;20:1322-1324. (Pubitemid 38807587)
61. Vladich FD, Brazille SM, Stern D, Peck ML, Ghittoni R, Vercelli D. IL-13 R130Q, a common variant associated with allergy and asthma, enhances effector mechanisms essential for human allergic inflammation. J Clin Invest. 2005;115:747-754. (Pubitemid 40322251)
62. Coop CA, Ronald W. Allergic fungal sinusitis presenting with proptosis and diplopia: a review of ophthalmologic complications and treatment. Allergy Asthma Proc. 2006;27:72-76.
63. Bartley GB. Evolution of classification systems for Graves' ophthalmopathy. Ophthalmic Plast Reconstr Surg. 1995;11:229-237. (Pubitemid 26007170)
64. Dolman PJ, Rootman J. VISA Classification for Graves orbitopathy. Ophthalmic Plast Reconstr Surg. 2006;22:319-324. (Pubitemid 44434337)